Analysis examines safety of antidepressant use during pregnancy

Pregnancy
Credit: CC0 Public Domain

Use of fluoxetine—the most commonly prescribed antidepressant—during pregnancy is linked with a slightly increased risk of malformations in infants, according to a recent analysis of published studies.

In the analysis of 16 studies, infants exposed to fluoxetine during the first trimester had an 18% increased relative risk of major and a 36% increased relative risk of cardiovascular malformations. There were no significant observations of other system-specific malformations in the nervous system, eye, urogenital system, digestive system, respiratory system, or musculoskeletal system.

The findings are published in the British Journal of Clinical Pharmacology.

Similar research was published at an earlier time in the British Journal of Clinical Pharmacology.


Explore further

Antidepressant drug linked with increased risk of birth defects when taken in early pregnancy

More information: Shan-Yan Gao et al, Fluoxetine and congenital malformations: a systematic review and meta-analysis of cohort studies, British Journal of Clinical Pharmacology (2017). DOI: 10.1111/bcp.13321
Provided by Wiley
Citation: Analysis examines safety of antidepressant use during pregnancy (2017, May 17) retrieved 27 January 2022 from https://medicalxpress.com/news/2017-05-analysis-safety-antidepressant-pregnancy.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
2 shares

Feedback to editors